Status:
COMPLETED
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Anemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study will assess the efficacy and safety of Mircera given intravenously in the treatment of renal anemia in chronic kidney disease patients on dialysis who are not currently receiving epoetin or...
Eligibility Criteria
Inclusion
- adult patients \>=18 years of age;
- chronic renal anemia;
- dialysis therapy for at least 2 weeks before screening.
Exclusion
- women who are pregnant, breastfeeding or using unreliable birth control methods;
- administration of any investigational drug within 4 weeks before screening.
Key Trial Info
Start Date :
February 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
182 Patients enrolled
Trial Details
Trial ID
NCT00077597
Start Date
February 1 2004
End Date
June 1 2006
Last Update
November 2 2016
Active Locations (59)
Enter a location and click search to find clinical trials sorted by distance.
1
Davis, California, United States, 95616
2
Lakewood, Colorado, United States, 80260
3
Atlanta, Georgia, United States, 30342
4
Augusta, Georgia, United States, 30901